Shea Butter

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: skin hair inflammation

Research Overview

Across the studies reviewed here, shea butter research is most developed in dermatologic and formulation contexts. It is frequently discussed as a plant oil with potential skin benefits (anti-inflammatory/antioxidant activity, barrier repair, and wound-healing support) and as a functional excipient in topical delivery systems. Multiple studies use shea butter as a lipid component in nanostructured lipid carriers (NLCs) or related platforms to improve stability and dermal delivery of poorly soluble actives (e.g., curcumin, orobol), emphasizing its role in materials science and pharmaceutics rather than as a stand-alone therapeutic. A smaller but notable clinical literature also places shea butter within multifunctional sunscreen formulations (as a “natural compound” potentially contributing to in vivo SPF) and documents its traditional use in neonatal cord care practices in northern Ghana, where it appears as a commonly applied salve within broader hygiene and infection-prevention behaviors.

The strongest evidence in these studies supports shea butter’s utility as a safe, well-tolerated topical base/excipient and as a component of lipid nanoparticle systems that can enhance topical delivery and stability of active compounds. In the thumb basal joint arthritis trial, shea butter served as the control vehicle and was used without reported adverse events, indirectly supporting tolerability in repeated application; however, the demonstrated clinical benefit was attributable to cannabidiol rather than shea butter itself. For drug delivery, the NLC studies provide comparatively direct experimental support that shea butter-containing lipid matrices can maintain active stability (e.g., orobol over weeks) and increase in vitro skin deposition, with at least one report of no significant irritation in a clinical assessment. Evidence for intrinsic therapeutic effects of shea butter on inflammatory skin disease, wound healing, or photoprotection is suggestive in review-level discussions but is less directly substantiated by the clinical outcome data presented here.

Key gaps include a need for more rigorous human studies isolating shea butter’s independent effects on clinically relevant endpoints (e.g., eczema severity, transepidermal water loss/barrier recovery, wound healing rates, and irritation/sensitization profiles across populations). For photoprotection, while clinical SPF studies of “natural compound” sunscreens are summarized, additional controlled trials are needed to quantify shea butter’s specific contribution to SPF/broad-spectrum protection and to clarify mechanisms (e.g., UV absorption vs. antioxidant/anti-inflammatory mitigation of UV damage). In pharmaceutics, further work is warranted to standardize shea butter composition (including effects of refining/fractionation on stability and performance), link physicochemical variability to delivery outcomes, and expand safety/efficacy testing of shea butter-based carriers in larger, longer-duration clinical studies. Finally, public health research should better evaluate the risks/benefits of traditional neonatal cord applications involving shea butter within infection-prevention frameworks, distinguishing product contamination and application practices from the material’s inherent properties.

1. What conditions has Shea Butter been studied for?

  • Skin inflammation, barrier repair, wound healing, and oxidative stress-related skin damage (as part of a broader review of plant oils’ topical effects, including shea butter).

  • Thumb basal joint arthritis pain and disability (as the vehicle/control comparator in a randomized controlled trial of topical cannabidiol (CBD) formulated in shea butter; shea butter alone served as the control arm).

  • Photoprotection / sunscreen efficacy (SPF) (review of clinical SPF studies including formulations containing natural compounds such as shea butter).

  • Topical drug delivery / dermatologic formulation science (as a lipid component in nanostructured lipid carriers/solid lipid nanoparticles for delivering actives such as curcumin, orobol, and fusidic acid).

  • Neonatal cord care practices (qualitative study in rural northern Ghana describing traditional application of shea butter and other substances to the umbilical cord; this is not an efficacy study, but relates to health practice and infection risk).

  • Metabolic outcomes in animals (mouse high-fat diet using shea butter as a stearic-acid–rich fat source to study thermogenesis/browning and lipid metabolism).

  • Quality/stability of refined vs crude/fractionated shea butter (food/cosmetic/pharmaceutical quality and stability focus rather than a clinical condition).

2. Does it work in treating those conditions? Summarize the evidence.

  • Skin barrier support / anti-inflammatory or antioxidant skin effects: The plant-oils review states that topical plant oils (including shea butter) have available data suggesting anti-inflammatory and antioxidant effects, plus promotion of wound healing and skin barrier repair. However, the study is a narrative overview and does not provide shea-butter–specific clinical effect sizes or trial details.

  • Thumb basal joint arthritis pain: In the randomized, double-blind crossover trial, participants received CBD in shea butter versus shea butter alone. The study reports that CBD treatment improved pain and disability scores compared with the control arm, with no adverse events. This supports efficacy for CBD, but does not demonstrate that shea butter alone treats arthritis pain (it functioned as the comparator/vehicle).

  • Photoprotection (SPF): A review of clinical SPF studies reports that sunscreens containing natural compounds (including shea butter) have had efficacy clinically established by SPF testing and suggests natural compounds can enhance in vivo SPF via different mechanisms. The study does not isolate shea butter’s independent SPF effect or quantify the magnitude attributable specifically to shea butter.

  • Drug delivery / formulation performance: Multiple formulation studies indicate that shea butter can be a useful lipid matrix in nanoparticles/films, improving delivery and/or stability of actives:

    • Curcumin delivery: A cellulose nanofiber film hybridized with curcumin-loaded NLCs found an optimized lipid composition containing shea butter showed the highest curcumin delivery to artificial skin (reported as 233.2 ± 96.6 μg/cm… in the truncated abstract).

    • Orobol delivery: A shea butter–based NLC maintained orobol stability for up to 28 days, increased in vitro deposition into Strat-M membranes and human cadaver skin, and did not cause significant skin irritation in a clinical study.

    • Fusidic acid delivery: Fusidic acid SLNs using shea butter as lipid phase were developed to address solubility limits; the optimized FA-SLN hydrogel showed nanoscale size, substantial entrapment, and was evaluated for irritation and antibacterial performance (details truncated, but the intent is improved topical delivery).

    These studies support shea butter’s role as a carrier/excipient that can improve topical delivery systems, but they do not necessarily prove shea butter alone treats a disease.

  • Neonatal cord care: The Ghana qualitative study reports shea butter is commonly applied to cords along with other traditional substances, and the authors emphasize that many cord-care practices involve non-sterile materials and should be addressed to prevent neonatal infections. This does not support efficacy; it raises potential safety/public health concerns about traditional application practices.

  • Metabolic effects (animal data): A mouse study compared high-fat diets enriched in different 18-carbon fatty acids, including a shea butter (stearic acid-rich) diet, to assess thermogenesis and lipid metabolism. The study is truncated, so specific outcomes for shea butter cannot be summarized from the provided text.

3. What health benefits does it have?

  • Potential skin anti-inflammatory and antioxidant effects: The plant-oils review highlights topical plant oils (including shea butter) for anti-inflammatory and antioxidant effects relevant to skin health and cutaneous homeostasis.

  • Skin barrier repair and wound-healing support (topical): The same review emphasizes promotion of wound healing and repair of the skin barrier as therapeutic benefits attributed to plant oils, including shea butter.

  • Potential contribution to photoprotection in formulations: The sunscreen clinical-studies review includes shea butter among natural compounds used in sunscreen systems with clinically established SPF, suggesting it may contribute to multifunctional photoprotective formulations (though the study does not quantify shea butter’s standalone SPF effect).

  • Formulation/biopharmaceutical benefits as an excipient: Several studies support shea butter as a functional lipid in topical delivery systems:

    • Enhanced stability of poorly stable actives (e.g., orobol stability maintained up to 28 days in shea butter–based NLCs).

    • Improved skin deposition/delivery of actives (e.g., increased in vitro deposition of orobol into membranes and cadaver skin; improved curcumin delivery to artificial skin in an optimized composition containing shea butter).

    • Potential to enable delivery of poorly soluble drugs (e.g., fusidic acid incorporated into shea butter-based SLNs to address solubility limitations).

4. Does it have any downsides or side effects?

  • Skin tolerability in the CBD trial vehicle: In the phase 1 skin test (10 healthy participants) using topical CBD formulated with shea butter, the study reports no adverse events after 1 week of twice-daily application. In the subsequent phase 2 trial, CBD in shea butter also showed improvements without adverse events. This suggests good tolerability of the formulation, but it does not isolate shea butter’s safety independent of CBD.

  • Low irritation signal in a shea butter–based nanoparticle system: The orobol NLC study reports the shea butter–based NLC formulation did not cause significant skin irritation in a clinical study (duration and sample size not provided in the study).

  • Potential infection risk when used in non-sterile neonatal cord care: The Ghana qualitative study describes applying shea butter (and other substances) to the umbilical cord as a common traditional practice and notes that many cord-care practices involve non-sterile materials. While not proving harm from shea butter itself, it highlights a plausible public health downside when topical substances are applied to a vulnerable site under non-sterile conditions.

  • Evidence limitations: Across the studies reviewed here, there is limited direct reporting of adverse effects attributable specifically to shea butter alone (as opposed to being part of a multi-ingredient formulation). Rare allergy/irritation is biologically plausible for topical products in general, but it is not addressed in these studies.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are reported in the studies reviewed here.

  • The clinical trial (CBD in shea butter vs shea butter alone), sunscreen review, plant-oils review, and formulation studies do not mention genotype-stratified responses or gene–ingredient interactions.

  • The mouse dietary-fat study concerns metabolic phenotypes but does not describe genetic variants beyond the use of a standard inbred strain (C57BL/6) in the truncated abstract.

Overall, based on these studies, there is insufficient evidence to claim shea butter is specifically beneficial or harmful for any particular genetic variation.

References

  1. Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils.
    Tzu-Kai Lin, Lily Zhong, Juan Luis Santiago (2017) - International journal of molecular sciences
  2. A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis.
    John T Heineman, Grace L Forster, Kristen L Stephens, Patrick S Cottler, Michael P Timko, Brent R DeGeorge (2022) - The Journal of hand surgery
  3. Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Nae-Won Kang, Min-Hwan Kim, Seo-Yeon Sohn, Ki-Taek Kim, Ju-Hwan Park, Sun-Young Lee, Jae-Young Lee, Dae-Duk Kim (2018) - Biomaterials
  4. In vivo SPF from multifunctional sunscreen systems developed with natural compounds-A review.
    Ana Lucía Morocho-Jácome, Thamires Batello Freire, Andressa Costa de Oliveira, Tânia Santos de Almeida, Catarina Rosado, Maria Valéria Robles Velasco, André Rolim Baby (2021) - Journal of cosmetic dermatology
  5. Clean delivery practices in rural northern Ghana: a qualitative study of community and provider knowledge, attitudes, and beliefs.
    Cheryl A Moyer, Raymond Akawire Aborigo, Gideon Logonia, Gideon Affah, Sarah Rominski, Philip B Adongo, John Williams, Abraham Hodgson, Cyril Engmann (2012) - BMC pregnancy and childbirth
  6. Effect of Refining and Fractionation Processes on Minor Components, Fatty Acids, Antioxidant and Antimicrobial Activities of Shea Butter.
    Adel G Abdel-Razek, Ghada A Abo-Elwafa, Eman F Al-Amrousi, Ahmed N Badr, Minar Mahmoud M Hassanein, Ying Qian, Aleksander Siger, Anna Grygier, Elżbieta Radziejewska-Kubzdela, Magdalena Rudzińska (2023) - Foods (Basel, Switzerland)
  7. Lipid Nanoparticles for Enhancing the Physicochemical Stability and Topical Skin Delivery of Orobol.
    Min-Hwan Kim, Yae-Eun Jeon, Soobeen Kang, Jae-Young Lee, Ki Won Lee, Ki-Taek Kim, Dae-Duk Kim (2020) - Pharmaceutics
  8. Improving the resolution of overlapping peaks by heartcut two-dimensional countercurrent chromatography with the same solvent system in both dimensions.
    Marco Müller, Medisa Murić, Lisa Glanz, Walter Vetter (2019) - Journal of chromatography. A
  9. Effects of Diets Differing in Composition of 18-C Fatty Acids on Adipose Tissue Thermogenic Gene Expression in Mice Fed High-Fat Diets.
    Sunhye Shin, Kolapo M Ajuwon (2018) - Nutrients
  10. The Role of Moisturizer Containing Anti-inflammatory on Skin Hydration in Mild-Moderate Atopic Dermatitis Patients.
    Cita Rosita Sigit Prakoeswa, Damayanti, Sylvia Anggraeni, Menul Ayu Umborowati, Maylita Sari, Made Putri Hendaria, Tanziela Firdausi Thahir (2024) - Dermatology research and practice
  11. Complementary and alternative medicine treatments for common skin diseases: A systematic review and meta-analysis.
    Virginia A Jones, Payal M Patel, Claire Wilson, Hongnan Wang, Kurt A Ashack (2021) - JAAD international
  12. Shea Butter Potentiates the Anti-Bacterial Activity of Fusidic Acid Incorporated into Solid Lipid Nanoparticle.
    Heba S Elsewedy, Tamer M Shehata, Wafaa E Soliman (2022) - Polymers
  13. A shea butter-based ketamine ointment: The antidepressant effects of transdermal ketamine in rats.
    Merve Akan, Ivan Skorodumov, Marcus W Meinhardt, Resit Canbeyli, Gunes Unal (2023) - Behavioural brain research
  14. Evidence-based treatment of atopic dermatitis with topical moisturizers.
    Giuseppe Micali, Valentina Paternò, Rossella Cannarella, Franco Dinotta, Francesco Lacarrubba (2018) - Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia
  15. Human dietary exposure to metals in the Niger delta region, Nigeria: Health risk assessment.
    Cecilia Nwadiuto Amadi, Beatrice Bocca, Flavia Ruggieri, Anthonett N Ezejiofor, Glad Uzah, Jose L Domingo, Joaquim Rovira, Chiara Frazzoli, Orish E Orisakwe (2022) - Environmental research
  16. African oils in dermatology.
    Olusola Ayanlowo, Olufolakemi Cole -Adeife, Margaret Ilomuanya, Cynthia Ebie, Abigail Adegbulu, Obumneke Ezeanyache, Oghogho Odiase, Viola Ikebudu, Basirat Akanbi (2022) - Dermatologic therapy
  17. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
    K L Hon, Y C Tsang, N H Pong, Vivian W Y Lee, N M Luk, C M Chow, T F Leung (2015) - Hong Kong medical journal = Xianggang yi xue za zhi
  18. Vulcanization kinetics and reinforcement behaviour of natural rubber-carbon black composites: Addition of Shea-butter versus aromatic oil as plasticizers.
    Bismark Mensah, Boateng Onwona-Agyeman, Frank Nsaful, Isaac Adjaye Aboagye, Nii Longdon Sowah, Prosper Naah Angnunavuri, Vitus Atanga Apalangya (2024) - Heliyon
  19. Effect of storage conditions on microbiological and physicochemical quality of shea butter.
    Fernande Honfo, Kerstin Hell, Noël Akissoé, Ousmane Coulibaly, Pascal Fandohan, Joseph Hounhouigan (2011) - Journal of food science and technology


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!